Document is current
Any future updates will be listed below
-
Authors
Lam, Marnix G. E. H.
Garin, Etienne
Fowers, Kirk D.
Mahvash, Armeen
Padia, Siddharth A.
Salem, Riad
- License Information
-
More Information
Article History
Received: 10 February 2025
Accepted: 8 May 2025
First Online: 22 May 2025
Declarations
:
: This article does not contain any studies with human participants or animals performed by any of the authors.
: Not applicable.
: Not applicable.
: Marnix Lam is a consultant to Boston Scientific, Novartis, Oncosil, BD, Terumo, and Quirem, and receives research support from Boston Scientific, Novartis, Terumo, and Quirem. Etienne Garin is a consultant for Boston Scientific. Kirk Fowers is a non-commercial employee of Boston Scientific Corporation. Armeen Mahvash is a consultant for Boston Scientific, Sirtex Medical, and ABK Biomedical. He received research support from Boston Scientific, Sirtex Medical, ABK Biomedical, and Siemens Healthineers. Siddharth Padia is a consultant for Boston Scientific, Guerbet, Johnson and Johnson, Teleflex Medical, and Varian Medical Systems. Riad Salem is a consultant for AstraZeneca, Bard, Boston Scientific, Cook, Eisai, Genentech, Sirtex, and QED Therapeutics.
